A plea to bridge the gap between antifungals and the management of onychomycosis

American Journal of Clinical Dermatology

Volumn 2, Issue 5, 2001, Pages 281-284

  Arrese, Jorge E ^a   Piérard Franchimont, Claudine ^a   Piérard, Gérald E ^a  

^a University in Liège   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; BIOASSAY; CORNEOFUNGIMETRY; DRUG EFFICACY; DRUG RESEARCH; FUNGICIDAL ACTIVITY; FUNGUS CULTURE; FUNGUS HYPHAE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ONYCHOMYCOSIS; PREDICTION; PRIORITY JOURNAL; REVIEW;

EID: 0034754026     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200102050-00002     Document Type: Review

References (3)

1. Piérard-Franchimont C, Deleixhe-Mauhin F, Piérard GE. Dermatophytose cutanée chronique, onychomycose occulte et hamartome épidermoïde linéaire: une impasse thérapeutique. J Mycol Med 1996; 6: 190-4
2. Elewski BE. Onychomycosis: treatment, quality of life and economic issues. Am J Clin Dermatol 2000; 1: 19-26
3. Arrese JE, Piérard-Franchimont C, Piérard GE. Facing up to the diagnostic uncertainty and management of onychomycoses. Int J Dermatol 1999; 38 Suppl. 2: 1-6